Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea
· Delayed Price · Currency is KRW
21,900
-100 (-0.45%)
Apr 29, 2026, 3:30 PM KST
Onconic Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 987,532 | 869,777 | 176,537 | - | - | - |
| Market Cap Growth | 251.06% | 392.69% | - | - | - | - |
| Enterprise Value | 934,923 | 816,363 | 152,373 | - | - | - |
| Last Close Price | 22000.00 | 19550.00 | 4085.00 | - | - | - |
| PE Ratio | 62.57 | 55.11 | - | - | - | - |
| PS Ratio | 18.50 | 16.29 | 11.90 | - | - | - |
| PB Ratio | 13.71 | 12.07 | 3.15 | - | - | - |
| P/TBV Ratio | 13.71 | 12.07 | 3.15 | - | - | - |
| P/FCF Ratio | 89.03 | 78.41 | - | - | - | - |
| P/OCF Ratio | 86.66 | 76.33 | - | - | - | - |
| EV/Sales Ratio | 17.51 | 15.29 | 10.27 | - | - | - |
| EV/EBITDA Ratio | 71.11 | 62.09 | - | - | - | - |
| EV/EBIT Ratio | 74.09 | 64.69 | - | - | - | - |
| EV/FCF Ratio | 84.29 | 73.60 | - | - | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | -0.72 | 0.00 | -0.02 |
| Debt / EBITDA Ratio | 0.01 | 0.01 | - | 5.26 | - | - |
| Debt / FCF Ratio | 0.01 | 0.01 | - | 4.74 | - | - |
| Net Debt / Equity Ratio | -0.73 | -0.73 | -0.76 | 0.81 | 1.24 | 2.34 |
| Net Debt / EBITDA Ratio | -4.00 | -4.00 | 9.82 | -6.28 | 1.85 | 2.25 |
| Net Debt / FCF Ratio | -4.74 | -4.74 | 5.35 | -5.34 | 1.56 | 2.11 |
| Asset Turnover | 0.78 | 0.78 | 0.30 | 0.62 | 0.00 | - |
| Quick Ratio | 17.48 | 17.48 | 10.61 | 0.54 | 1.06 | 36.08 |
| Current Ratio | 17.62 | 17.62 | 10.94 | 0.54 | 1.06 | 36.10 |
| Return on Equity (ROE) | 24.65% | 24.65% | -44.55% | - | - | - |
| Return on Assets (ROA) | 11.55% | 11.55% | -6.09% | 4.07% | -36.85% | - |
| Return on Capital Employed (ROCE) | 17.50% | 17.50% | -8.50% | -11.50% | -343.70% | -44.10% |
| Earnings Yield | 1.60% | 1.81% | -4.58% | - | - | - |
| FCF Yield | 1.12% | 1.27% | -4.52% | - | - | - |
| Buyback Yield / Dilution | - | - | -41.46% | 0.00% | -0.94% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.